221 related articles for article (PubMed ID: 31439678)
1. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.
Egan C; Nicolae A; Lack J; Chung HJ; Skarshaug S; Pham TA; Navarro W; Abdullaev Z; Aguilera NS; Xi L; Pack S; Pittaluga S; Jaffe ES; Raffeld M
Haematologica; 2020 Apr; 105(4):951-960. PubMed ID: 31439678
[TBL] [Abstract][Full Text] [Related]
2. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma.
Shanmugam V; Griffin GK; Jacobsen ED; Fletcher CDM; Sholl LM; Hornick JL
Mod Pathol; 2019 Jun; 32(6):830-843. PubMed ID: 30626916
[TBL] [Abstract][Full Text] [Related]
3. The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.
Egan C; Lack J; Skarshaug S; Pham TA; Abdullaev Z; Xi L; Pack S; Pittaluga S; Jaffe ES; Raffeld M
Mod Pathol; 2021 Feb; 34(2):336-347. PubMed ID: 32929178
[TBL] [Abstract][Full Text] [Related]
4. PTPN11 mutations in canine and human disseminated histiocytic sarcoma.
Hédan B; Rault M; Abadie J; Ulvé R; Botherel N; Devauchelle P; Copie-Bergman C; Cadieu E; Parrens M; Alten J; Zalcman EL; Cario G; Damaj G; Mokhtari K; Le Loarer F; Coulomb-Lhermine A; Derrien T; Hitte C; Bachelot L; Breen M; Gilot D; Blay JY; Donadieu J; André C
Int J Cancer; 2020 Sep; 147(6):1657-1665. PubMed ID: 32212266
[TBL] [Abstract][Full Text] [Related]
5. Activating Mutations in
Takada M; Smyth LA; Thaiwong T; Richter M; Corner SM; Schall PZ; Kiupel M; Yuzbasiyan-Gurkan V
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31277422
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations in histiocytic sarcoma identified by next generation sequencing.
Liu Q; Tomaszewicz K; Hutchinson L; Hornick JL; Woda B; Yu H
Virchows Arch; 2016 Aug; 469(2):233-41. PubMed ID: 27259537
[TBL] [Abstract][Full Text] [Related]
7. Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.
Hoffmann L; Coras R; Kobow K; López-Rivera JA; Lal D; Leu C; Najm I; Nürnberg P; Herms J; Harter PN; Bien CG; Kalbhenn T; Müller M; Pieper T; Hartlieb T; Kudernatsch M; Hamer H; Brandner S; Rössler K; Blümcke I; Jabari S
Acta Neuropathol; 2023 Jun; 145(6):815-827. PubMed ID: 36973520
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.
Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M
Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581
[TBL] [Abstract][Full Text] [Related]
9. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
10. Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.
Zhao Y; Yu H; Ida CM; Halling KC; Kipp BR; Geiersbach K; Rumilla KM; Gupta S; Lin MT; Zheng G
JAMA Netw Open; 2021 Jan; 4(1):e2035479. PubMed ID: 33507258
[TBL] [Abstract][Full Text] [Related]
11. BRAF
Vaughn JL; Freitag CE; Hemminger JA; Jones JA
J Med Case Rep; 2017 Apr; 11(1):92. PubMed ID: 28376906
[TBL] [Abstract][Full Text] [Related]
12. Histiocytic Sarcoma.
Hung YP; Qian X
Arch Pathol Lab Med; 2020 May; 144(5):650-654. PubMed ID: 31070934
[TBL] [Abstract][Full Text] [Related]
13. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.
Kaplan HG; Rostad S; Ross JS; Ali SM; Millis SZ
J Natl Compr Canc Netw; 2018 Aug; 16(8):967-974. PubMed ID: 30099373
[No Abstract] [Full Text] [Related]
15. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.
Kordes M; Röring M; Heining C; Braun S; Hutter B; Richter D; Geörg C; Scholl C; Gröschel S; Roth W; Rosenwald A; Geissinger E; von Kalle C; Jäger D; Brors B; Weichert W; Grüllich C; Glimm H; Brummer T; Fröhling S
Leukemia; 2016 Apr; 30(4):937-46. PubMed ID: 26582644
[TBL] [Abstract][Full Text] [Related]
17. A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review.
Zhang L; Zhang G; Zheng H; Jiang B; Ju Y; Duan Q; An L; Shi H
Brain Tumor Pathol; 2024 Jan; 41(1):18-29. PubMed ID: 38100030
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.
Sangha N; Wu R; Kuick R; Powers S; Mu D; Fiander D; Yuen K; Katabuchi H; Tashiro H; Fearon ER; Cho KR
Neoplasia; 2008 Dec; 10(12):1362-72, following 1372. PubMed ID: 19048115
[TBL] [Abstract][Full Text] [Related]
19. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas.
Chen W; Lau SK; Fong D; Wang J; Wang E; Arber DA; Weiss LM; Huang Q
Am J Surg Pathol; 2009 Jun; 33(6):863-73. PubMed ID: 19145200
[TBL] [Abstract][Full Text] [Related]
20. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
